Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
Gordon C Ibeanu,1 Adekunle B Rowaiye,1,2 Joy C Okoli,1 Daniel U Eze1 1Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, 27707, USA; 2Department of Agricultural Biotechnology, National Biotechnology Development Agency, Abuja, NigeriaCorrespondence: Adekunle B Rowai...
Saved in:
| Main Authors: | Ibeanu GC, Rowaiye AB, Okoli JC, Eze DU |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | ImmunoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/microbiome-differences-in-colorectal-cancer-patients-and-healthy-indiv-peer-reviewed-fulltext-article-ITT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery
by: Inka Sastalla, et al.
Published: (2025-01-01) -
Nanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations
by: Patricio G. Márquez, et al.
Published: (2024-12-01) -
Nanoparticles as Delivery Systems for Antigenic Saccharides: From Conjugation Chemistry to Vaccine Design
by: Marie-Jeanne Archambault, et al.
Published: (2024-11-01) -
Chemical cross‐linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual‐antigen subunit vaccine
by: Long Chen, et al.
Published: (2025-01-01) -
Identification of immunogenic antigens and evaluation of vaccine candidates against Clostridium perfringens
by: Zewei Li, et al.
Published: (2024-12-01)